Literature DB >> 3004364

[Basic study of anti-cancer agents suspended in lipiodol].

H Taniguchi, T Yamaguchi, T Takahashi.   

Abstract

Anti-cancer agents suspended in Lipiodol have been proved to be effective in the targeting of chemotherapy for cancer of the digestive organs. 5-FU, ADM and MMC were suspended both separately and collectively in Lipiodol. These preparations were terned FULIP, ADRLIP, MMCLIP and FAMLIP, respectively. Forty percent 5-FU was released from FULIP within 24 hours. ADM and MMC were released more slowly from ADRLIP and MMCLIP when compared with FULIP. ADM W/O type emulsion (ADM was dissolved in 60% Urographin/Lipiodol) released ADM so rapidly that 37% of the drug was detected in the water phase within 10 hours. However, the ADM W/O emulsion with Arlacel-A was much slower. From these results, it was suggested that the release speed of anti-cancer agents can be controlled by modifying the drug dosage and form. FAMLIP released 5-FU, ADM and MMC independently and the release speeds were equal to FULIP, ADRLIP and MMCLIP. It was also suggested that the biological activities of 5-FU, ADM and MMC in FAMLIP were stable in FULIP, ADRLIP and MMCLIP. It should therefore be possible to use a large amount of anti-cancer agent suspended in Lipiodol, as a combined drug cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004364

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  4 in total

1.  Adriamycin-lipiodol suspension for i.a. chemotherapy of hepatocellular carcinoma.

Authors:  Y Katagiri; K Mabuchi; T Itakura; K Naora; K Iwamoto; Y Nozu; S Hirai; N Ikeda; T Kawai
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension.

Authors:  Y Horiguchi; M Itoh; H Takagawa; H Imai; A Kamei; B Sekoguchi; Y Nagamura
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.

Authors:  M Kanematsu
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

4.  Comparison of epirubicin-iodized oil suspension and emulsion for transcatheter arterial chemoembolization in VX2 tumor.

Authors:  Tatsuo Ueda; Satoru Murata; Takahiko Mine; Shiro Onozawa; Munehiko Onda; Zenya Naito; Yasuo Amano; Shinichiro Kumita
Journal:  ScientificWorldJournal       Date:  2012-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.